| Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676) |
|---|
| 03/26/2002 | US6362231 Calcium receptor active compounds |
| 03/26/2002 | US6362229 Inhibitors of multidrug transporters |
| 03/26/2002 | US6362210 Carboxylic acid amides, pharmaceutical compositions containing these compounds and their use |
| 03/26/2002 | US6362199 Central nervous system disorders; psychological disorders |
| 03/26/2002 | US6362198 Anticholesterol, antilipemic agent |
| 03/26/2002 | US6362193 Antiinflammatory agents |
| 03/26/2002 | US6361920 Photographic material containing a novel hydrazide type |
| 03/21/2002 | WO2002022618A1 Method for preparing camptothecin and its derivatives |
| 03/21/2002 | WO2002022599A2 Chemokine receptor binding heterocyclic compounds |
| 03/21/2002 | WO2002022585A1 Tetrahydroquinoline compounds |
| 03/21/2002 | WO2002022581A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 03/21/2002 | WO2002022556A1 Novel amide derivatives and medicinal use thereof ugs |
| 03/21/2002 | WO2002022551A1 Derivatives of naphthalene with comt inhibiting activity |
| 03/21/2002 | WO2002022126A1 Gatifloxacin pentahydrate |
| 03/21/2002 | US20020035136 Amino(oxo) acetic acid protein tyrosine phosphatase inhibitors |
| 03/21/2002 | US20020035127 Phenylalanine derivatives |
| 03/21/2002 | US20020035125 Therapeutic combination |
| 03/21/2002 | US20020035121 Aryl fused substituted 4-oxy-pyridines |
| 03/21/2002 | DE19940394C2 Fluorochrome und deren Verwendung Fluorochromes and their use |
| 03/21/2002 | CA2422616A1 Gatifloxacin pentahydrate |
| 03/21/2002 | CA2422137A1 Tetrahydroquinoline compounds |
| 03/21/2002 | CA2422044A1 Nitrogen-containing compounds and their use as glycine transport inhibitors |
| 03/21/2002 | CA2419219A1 Chemokine receptor binding heterocyclic compounds |
| 03/20/2002 | EP1188733A1 Method of continuously and selectively separating clathrate and apparatus therefor |
| 03/20/2002 | EP1188439A2 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 03/20/2002 | EP1187828A1 Quinoline derivatives as antibacterials |
| 03/20/2002 | EP1187817A1 Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 03/20/2002 | EP0944590B1 Aminoguanidines and alkoxyguanidines as protease inhibitors |
| 03/20/2002 | CN1341104A 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases |
| 03/19/2002 | US6359138 4-hydroxy-piperidine derivatives |
| 03/19/2002 | US6359135 Compounds having activity as inhibitors of cytochrome P450RAI |
| 03/19/2002 | US6358993 Pharmaceutically active nitrogen ring compounds and methods of use thereof |
| 03/19/2002 | US6358976 For therapy and prophylaxis of cancer metastasis, diabetic retinopathy, neovascular glaucoma, thrombosis, restenosis, osteoporosis, or macular degeneration |
| 03/19/2002 | US6358948 Quinazolinone and benzoxazine derivatives as progesterone receptor modulators |
| 03/14/2002 | WO2002020526A2 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | WO2002020490A2 Process to produce halo-4-phenoxyquinolines |
| 03/14/2002 | WO2002020489A2 QUINOLINE INHIBITORS OF cGMP PHOSPHODIESTERASE |
| 03/14/2002 | WO2002020488A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 03/14/2002 | WO2002020465A2 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | WO2001070734A3 Beta-amino acid derivatives as inhibitors of matrix metalloproteases and tnf-alpha |
| 03/14/2002 | WO2001070673A3 CYCLIC β-AMINO ACID DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEASES AND TNF-$g(a) |
| 03/14/2002 | US20020032333 Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide |
| 03/14/2002 | US20020032330 Propionic acid derivatives |
| 03/14/2002 | US20020032238 Lowering the plasma level of atherogenic lipoproteins; treating hyperlipidaemias, atherosclerosis or the clinical sequelae thereof, diabetes mellitus, adiposity or pancreatitis |
| 03/14/2002 | US20020032202 Administering a pharmaceutically effective dose of the heterocycle-containing carboxylic acid derivative or salt to a patient suffering form acute promyelocytic leukemia |
| 03/14/2002 | US20020032189 Amine compounds, their production and use |
| 03/14/2002 | US20020032186 N-hydroxy-2-(alkyl, aryl, or heteroaryl sulfanyl, sulfinyl or sulfonyl)-3-substituted alkyl, aryl or heteroarylamides as matrix metalloproteinase inhibitors |
| 03/14/2002 | DE10043659A1 Arylpiperazinderivate Arylpiperazinderivate |
| 03/14/2002 | CA2421506A1 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binding agents |
| 03/14/2002 | CA2421172A1 Gamma-ketoacid dipeptides as inhibitors of caspase-3 |
| 03/14/2002 | CA2420703A1 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor |
| 03/13/2002 | EP1186594A1 N-alkoxyalkyl-n,n-dialkylamine derivatives or salts thereof, and remedies for nerve degeneration diseases containing the same |
| 03/13/2002 | EP1185261A1 Il-8 receptor antagonists |
| 03/13/2002 | EP0871616B1 Process for the preparation of anti-malarial drugs |
| 03/13/2002 | CN1340051A Heteroaryl-substituted quinoline-2-one derivatives useful asticancer agents |
| 03/12/2002 | US6355810 Multibinding inhibitors of HMG-CoA reductase |
| 03/12/2002 | US6355805 β3-adrenergic receptor agonists |
| 03/12/2002 | US6355673 Substituted diaminocarboxylic acids |
| 03/12/2002 | US6355668 Bicycloloactam compounds, use thereof and intermediates for preparing thereof |
| 03/12/2002 | US6355654 Salts of quinoline derivatives as NK3 antagonists |
| 03/07/2002 | WO2002018361A2 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | WO2002018345A1 Quinoline antibacterial compounds and methods of use thereof |
| 03/07/2002 | WO2002018344A1 Novel ester or amide derivatives |
| 03/07/2002 | WO2002018343A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 03/07/2002 | WO2002018342A2 Novel autoinducer molecules and uses therefor |
| 03/07/2002 | WO2002018333A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | WO2002018327A2 Guanidinobenzamides as mc4-r agonists |
| 03/07/2002 | WO2002018321A2 Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| 03/07/2002 | WO2002017916A1 Antiviral and antimicrobial guanidine or biguanidine derivatives |
| 03/07/2002 | WO2002017712A2 Disubstituted benzenes as insecticides |
| 03/07/2002 | US20020028950 Guanidinylamino heterocycle compunds useful as alpha-2 adrenoceptor agonists |
| 03/07/2002 | US20020028943 For lowering serum lipid, cholesterol and/or triglyceride levels; treating atherosclerosis |
| 03/07/2002 | US20020028836 Potassium channel openers |
| 03/07/2002 | US20020028821 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 03/07/2002 | US20020028812 Phenylalanine derivatives |
| 03/07/2002 | DE10035928A1 Neue Heteroaryl-Derivate und deren Verwendung als Arzneimittel New heteroaryl derivatives and their use as medicaments |
| 03/07/2002 | CA2420969A1 Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
| 03/07/2002 | CA2420869A1 Compounds having activity as inhibitors of cytochrome p450rai |
| 03/07/2002 | CA2419616A1 Novel ester or amide derivatives |
| 03/07/2002 | CA2386552A1 Method for synthesizing flosequinan from 4-fluoroanthranilic acid |
| 03/06/2002 | EP1183240A1 Beta2-adrenoceptor agonists |
| 03/06/2002 | EP1183229A1 Glucagon antagonists/inverse agonists |
| 03/06/2002 | EP0907648B1 Quinolone carboxylic acids substituted by 7-(3-vinyl-1,4-piperazine-1-yl) |
| 03/06/2002 | CN1338455A Process for preparing quinolone carboxylic acid |
| 03/05/2002 | US6353119 Preparation of 3-substituted-4-arylquinolin-2-one derivatives |
| 03/05/2002 | US6353099 Substituted ureas as cell adhesion inhibitors |
| 03/05/2002 | US6353017 Inhibitors of cathespins using dipeptide nitriles as antiinflammatory agents and antiarthritic agents |
| 03/05/2002 | US6352989 Nitrogenous heterocyclic derivatives and medicine thereof |
| 02/28/2002 | WO2002016310A1 Selective androgen receptor modulators and methods of use thereof |
| 02/28/2002 | WO2002015942A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 02/28/2002 | WO2001068593A3 Amino acid derivatives as hiv aspartyl protease inhibitors |
| 02/28/2002 | WO2001046200A8 Novel piperidine and piperazine derivatives |
| 02/28/2002 | WO2001042216A3 Caspase inhibitors and uses thereof |
| 02/28/2002 | WO2000067746A8 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors |
| 02/28/2002 | US20020026060 RAR selective retinoid agonists |
| 02/28/2002 | US20020026052 Antineoplastic agents, agents for treatment of osteoporosis and polycystic kidney disease |
| 02/28/2002 | CA2452346A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 02/27/2002 | EP1182194A1 Pernasal preparations |
| 02/27/2002 | EP1182183A1 Anthracene derivatives and organic electroluminescent devices made by using the same |
| 02/27/2002 | EP1181273A1 New process |